ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
VolitionRx Limited (VNRX) stock declined over -2.00%, trading at $0.49 on AMEX, down from the previous close of $0.50. The stock opened at $0.50, fluctuating between $0.46 and $0.51 in the recent session.
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
Employees | 96 |
Beta | 1.1 |
Sales or Revenue | $775.30K |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Diagnostics & Research |
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep